Company News
Segro gives confident outlook with Tritax Eurobox takeover on track
Real estate group Segro said its business is performing well heading into the final months of the year as it progresses its £550m takeover of Tritax Eurobox, which is expected to close in the fourth quarter.
Pantheon Infrastructure NAV rises 6.5pc in first half
Pantheon Infrastructure reported a 6. 5% increase in net asset value (NAV) to £535m for the six months ended 30 June on Thursday, or 113. 9p per share.
Videndum lowers full-year forecasts as film and TV productions remain slow
Videndum, an international provider of premium branded hardware products and software solutions to the content creation market, reported a 7% decline in revenue from continuing operations to £153. 3m for its first half on Thursday, down from £165m a year earlier, as it warned that the full year would be below its previous expectations.
Halma backs FY guidance after progress in first half
Halma backed its guidance for the full year on Thursday as it said further progress was made in the first half in trading conditions "which remain varied across our end markets".
Dar Global swings to net loss as revenue more than halves
Dar Global reported a first-half net loss of $12. 8m on Thursday, contrasting sharply with a profit of $20. 8m during the same period last year.
Life Science REIT reports positive first-half progress
Life Science REIT reported a positive first-half performance on Thursday, driven by development progress and a rebound in the occupier market, which supported earnings growth.
Downing Renewables in exclusive talks to sell Gabrielsberget wind farm
Downing Renewables announced on Thursday that it is in exclusive discussions regarding the sale of its entire interest in the Gabrielsberget wind farm in Sweden.
CVS Group confident despite tough year for UK vet market
Veterinary practice operator CVS Group reported a 9. 9% increase in full-year revenue on Thursday, to £647. 3m, reflecting its ongoing expansion efforts, particularly in Australia.
AstraZeneca's Tagrisso gets new US lung cancer approval
AstraZeneca announced on Thursday that ‘Tagrisso’, or osimertinib, has been approved by the US Food and Drug Administration (FDA) for the treatment of adult patients with unresectable, stage three epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC), whose disease had not progressed after platinum-based chemoradiation therapy (CRT).
Schroders appoints two new execs to the board
Schroders has moved its chief operating officer into the chief financial officer position, after its former finance lead was promoted to chief executive earlier this month.
Mitchells & Butlers Q4 sales hit by wet weather, UK riots
UK's pub group Mitchells & Butlers on Thursday said fourth-quarter like-for-like sales slowed as riots in city centres and an unseasonably wet summer hit trade but added that it still expected to deliver annual results at the upper end of consensus expectations.
Pennon sees lower customer demand as consumption falls
FTSE 250-listed water and sewerage group Pennon said like-for-like revenues in the first half were impacted by lower customer demand, which is expected to continue through to the end of the financial year.